Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Proteostasis Therapeutics Inc (NASDAQ:PTI)

4.99
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
1.41
Today|||52-Week Range
16.67
-59.30%
Year-to-Date
Proteostasis Stock Surges on Positive Data From CF Studies
Dec 13 / Zacks.com - Paid Partner Content
That Wild Market Momentum Has Cooled
Dec 12 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close4.99
Today’s open4.79
Day’s range4.52 - 5.04
Volume1,369,200
Average volume (3 months)646,932
Market cap$125.8M
Data as of 4:00pm ET, 12/15/2017

Growth & Valuation

Earnings growth (last year)-119.97%
Earnings growth (this year)-20.55%
Earnings growth (next 5 years)--
Revenue growth (last year)+94.43%
P/E ratioNM
Price/Sales27.43
Price/Book1.53

Competitors

 Today’s
change
Today’s
% change
CDNACareDx Inc0.000.00%
MBOTMicrobot Medical Inc0.000.00%
TROVTrovagene Inc0.000.00%
ONCSOncoSec Medical Inc0.000.00%
Data as of 4:00pm ET, 12/15/2017

Financials

Next reporting dateFebruary 28, 2018
EPS forecast (this quarter)-$0.65
Annual revenue (last year)$8.4M
Annual profit (last year)-$37.2M
Net profit margin-444.08%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Meenu Chhabra Karson
Chief Financial Officer &
Treasurer
Helen M. Boudreau
Corporate headquarters
Cambridge, Massachusetts

Forecasts